Detection of DCC mutations in fecal specimens is not well studied; however, KRAS, TP53, and APC are well reported in the English literature, as, for example, Calistri's study reports that K-ras and p53 were equally altered in 35% of CRC patients and APC mutations were reported in 13% [37]. Here, TP53 is linked to colorectal carcinoma.